CasNo.439081-18-2,Afatinib (CAS: 439081-18-2),(439081-18-2) Suppliers

100 Gram	Negotiable

Min.Order :100 Gram
Purity: 99
Payment Terms : L/C,T/T,,MoneyGram

Keywords

raw material API anticancer

Quick Details

Appearance:
Application:Anticancer Raw Material
PackAge:Aluminum Foil Bag or Fiber Drum
ProductionCapacity:100|Metric Ton|Month
Storage:
Transportation:EMS

Superiority:

Afatinib (CAS: 439081-18-2)

Product Name: Afatinib

Other Names:Afatinib;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;4-[(3-chloro-4-fluorophenyl)aMino]-6-{[4-(N,N-diMethylaMino)-1-oxo-2-buten-1-yl]aMino}-7-((S)-tetrahydrofuran-3-yloxy)-quinazoline;2-ButenaMide, N-[4-[(3-chloro-4-fluorophenyl)aMino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(diMethylaMino)-, (2E)-;(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dime;Afatinib API;Afatinib(BIBW2992MA2);Afatinib (with 1 int.)

CAS No.: 439081-18-2

Molecular Formula: C24H25ClFN5O3

Molecular Weight: 485.94

Purity: 99%+

Product Specifications: Pharmaceutical Grade

MOQ(Minimum Order Quantity): 10g

Payment: L/C, T/T,

Product Description

Afatinib (INN; trade name Gilotrif in the US and Giotrif in Europe, previously Tomtovok and Tovok) is a drug approved in United States, Europe, Taiwan, Mexico, Chile and Japan as well as other countries for the first-line treatment of patients with distinct types of metastatic (EGFR mutation positive) non-small cell lung carcinoma (NSCLC), developed by Boehringer Ingelheim. It acts as an irreversible covalent inhibitor of the receptor tyrosine kinases epidermal growth factor receptor (EGFR) and erbB-2 (HER2).

Small Molecular API List:

No.	CAS No.	Product Name
1	86639-52-3	7-Ethyl-10-Hydroxycamptothecin
2	154229-18-2	Abiraterone Acetate
3	50-76-0	Actinomycin D
4	106941-25-7	Adefovir
5	850140-72-6	Afatinib
6	330784-47-9	Avanafil
7	319460-85-0	Axitinib
8	1421373-66-1	AZD-9291 (Mesylate)
9	123524-52-7	Azelnidipine
10	863031-21-4	Azilsartan Medoxomil
11	179324-69-7	Bortezomib
12	357336-20-0	Brivaracetam
13	842133-18-0	Canagliflozin
14	928672-86-0	Canagliflozin HemiHydrate
15	41575-94-4	Carboplatin
16	50935-04-1	Carubicin
17	288383-20-0	Cediranib
18	15663-27-1	Cisplatin
19	877399-52-5	Crizotinib
20	171500-79-1	Dalbavancin

Term & Condition:

Minimum Order Quantity	100g
Price	Negotiable
Lead Time	5-14 Days After Payment
Packaging Details	Aluminum Foil Bags or Fiber Drum
Trade Terms	CIF,CFR,FOB
Payment Terms	T/T,L/C,West Union, Money Gram

Delivery:

1) Products can be sent out within 24 hours after payment.

2) Secure and discreet shipment.

3) Various methods for your choice, like DHL/FedEx/SF-express.

Commitment:

1. We are manufacturer with own factory and we sale this product at a best quality and low price.
2. This product is available in stock, please contact the sale for more details.
3. We have QA & QC department to guarantees the ex-factory product pass rate can reach 100%.

====================

Contact Info:

Telephone: +86-027-87002705

Mobile: +86-13638641831 +86-13277093700
WhatsApp & Telegram: +86-13638641831
Skype: newbiopharmtech

FaceBook: #

Website: #

Online Store: #

Newbio is a reliable supplier, hoping to enter businesss really soon!!!

Details:

Afatinib (CAS: 439081-18-2)

Product Name: Afatinib

Other Names:Afatinib;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;4-[(3-chloro-4-fluorophenyl)aMino]-6-{[4-(N,N-diMethylaMino)-1-oxo-2-buten-1-yl]aMino}-7-((S)-tetrahydrofuran-3-yloxy)-quinazoline;2-ButenaMide, N-[4-[(3-chloro-4-fluorophenyl)aMino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(diMethylaMino)-, (2E)-;(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dime;Afatinib API;Afatinib(BIBW2992MA2);Afatinib (with 1 int.)

CAS No.: 439081-18-2

Molecular Formula: C24H25ClFN5O3

Molecular Weight: 485.94

Purity: 99%+

Product Specifications: Pharmaceutical Grade

MOQ(Minimum Order Quantity): 10g

Payment: L/C, T/T,

Product Description

Afatinib (INN; trade name Gilotrif in the US and Giotrif in Europe, previously Tomtovok and Tovok) is a drug approved in United States, Europe, Taiwan, Mexico, Chile and Japan as well as other countries for the first-line treatment of patients with distinct types of metastatic (EGFR mutation positive) non-small cell lung carcinoma (NSCLC), developed by Boehringer Ingelheim. It acts as an irreversible covalent inhibitor of the receptor tyrosine kinases epidermal growth factor receptor (EGFR) and erbB-2 (HER2).